Type 2 diabetes: symptoms, medications & what you can do yourself

At a glance

Affected in Germany ~10.3% of adults with known diabetes; on top of that comes an estimated number of unreported cases
Share Over 90% of all diabetes cases
Cause Generally insulin resistance + relative insulin deficiency; an interplay of genetics and lifestyle factors
Remission Possible in individual cases — especially in the first years through weight loss and a lifestyle change
Medications (selection) Metformin, SGLT2 inhibitors (e.g. empagliflozin), GLP-1 RAs (e.g. semaglutide, tirzepatide), insulin if needed
ICD-10 E11

1. What is type 2 diabetes?

Type 2 diabetes is a chronic metabolic disease in which two problems generally come together: the body's cells no longer react sufficiently to insulin (insulin resistance) and over time the pancreas can mostly no longer fully compensate for the rising demand (relative insulin deficiency). The blood sugar remains permanently elevated and can gradually damage vessels, nerves and organs.

In Germany, the prevalence of known diabetes was around 10.3% of adults according to the Robert Koch Institute (panel evaluation 2024).³ Type 2 makes up by far the largest part of all diabetes cases.

Remission is possible Type 2 is currently the only form of diabetes for which a remission is described. Especially in the first years after the diagnosis, weight loss, a dietary change and regular movement can in some cases normalize the blood sugar so far that no medications are needed for a time.¹

2. Symptoms — often unnoticed for years

The insidious thing about type 2: the disease generally develops gradually over months to years. For a long time, many of those affected have no or only nonspecific complaints — and the diabetes is often only discovered during routine examinations or in the context of secondary diseases.

  • increased thirst and frequent urination — sometimes at night too
  • fatigue and a drop in performance without a clear cause
  • increased susceptibility to infection — especially urinary tract infections and fungal infections
  • poorly healing wounds
  • visual disturbances — e.g. temporarily blurred vision due to changes in the lens of the eye
  • tingling or numbness in the hands and feet (possible indications of polyneuropathy)
  • itching, dry skin
  • dark patches of skin in skin folds (acanthosis nigricans — can point to insulin resistance)
Get tested early — even without complaints A not-small portion of people in Germany live with an undetected diabetes.³ From about the mid-30s, have the blood sugar checked too at the health check-up — a simple blood test is generally enough.

3. Prediabetes: recognizing the precursor and acting

Prediabetes is a precursor of type 2 diabetes: the blood sugar is already elevated, but not yet in the diabetes range. Without countermeasures, a manifest diabetes develops over the course in many cases.¹

Guiding values for prediabetes Fasting blood sugar 100–125 mg/dl (5.6–6.9 mmol/l) OR HbA1c 5.7–6.4% OR a 2-hour value in the OGTT between 140 and 199 mg/dl.
In this phase a lot can still be achieved Studies on lifestyle intervention with prediabetes have shown that a combination of a balanced diet, regular movement and moderate weight loss can considerably lower the risk — in some studies the effect was even greater than under medications.¹

Warning signals for an increased risk: an increased waist circumference (> 80 cm in women, > 94 cm in men), a familial burden with diabetes, dark patches of skin (acanthosis nigricans) or a previous gestational diabetes.


4. Causes and risk factors

Main risk factors

  • Excess weight/obesity — considered the most important influenceable factor. Especially visceral abdominal fat increases the risk
  • Lack of exercise — can directly favor insulin resistance, also independently of weight
  • Genetic predisposition — diabetes in first-degree relatives can increase the risk
  • Age — the risk rises from middle age; increasingly, however, younger adults are affected too
  • Socioeconomic factors — people in education groups with a lower socioeconomic status are affected considerably more often³

Further risk factors

  • previous gestational diabetes
  • PCOS (polycystic ovary syndrome)
  • chronic sleep deprivation and sleep apnea
  • certain medications (e.g. longer cortisone therapy, certain antipsychotics)
  • smoking — increases the risk for type 2 in studies
  • unfavorable dietary patterns (a lot of sugar, many highly processed foods)

5. Diagnosis

The diagnosis is generally made via defined laboratory values. For a reliable diagnosis, two pathological laboratory values are mostly required according to the current guideline.¹

  • Fasting blood sugar ≥ 126 mg/dl (7.0 mmol/l) — generally confirmed on two different days
  • HbA1c ≥ 6.5% (48 mmol/mol) — the "long-term blood sugar" of the last 2–3 months
  • 2-hour value in the OGTT ≥ 200 mg/dl (11.1 mmol/l)
  • Random blood sugar ≥ 200 mg/dl with simultaneously typical symptoms
Extended basic screening after a new diagnosis Blood pressure, blood lipids (cholesterol, triglycerides), kidney values (eGFR, albumin in the urine), liver values, an ophthalmological examination, foot status.

More: Preparing for a doctor's appointment.


6. Treatment without medications — the basic therapy

The basic therapy is the cornerstone of every type 2 diabetes treatment. In the first years after the diagnosis it can in individual cases even lead to a remission.¹

Diet

  • A special "diabetic diet" is generally not necessary — a balanced, wholesome diet is mostly enough
  • The Mediterranean diet has good evidence in studies: a lot of vegetables, fruit, legumes, whole-grain products, olive oil, fish; little red meat and little sugar
  • consistently reduce sugar and sweet drinks — mostly with the largest single effect
  • reduce highly processed foods where possible
  • eat fiber-rich foods — fiber generally slows down the absorption of sugar
  • intermittent fasting (e.g. 16:8) can be an effective strategy

Movement

  • Generally recommended: about 150–300 minutes of moderate activity per week (e.g. brisk walking, swimming, cycling)
  • a combination of endurance and strength training — building muscle can improve insulin sensitivity
  • interrupt sitting times regularly
  • every bit of movement counts — short sessions too are generally better than none
Use the DMP Diabetes People with type 2 diabetes generally have a claim to participation in the disease management program (DMP) Diabetes. It includes structured education sessions, regular checks and nutritional counseling. Enrollment usually with the GP.

7. Medications: step therapy according to the NVL

When lifestyle measures are not sufficient, medications are additionally used. The selection generally depends on accompanying diseases and the individual risk profile.¹˒²

The basic principle of the NVL 2024 With an existing cardiovascular or kidney disease, SGLT2 inhibitors or GLP-1 receptor agonists are generally used early — not only after a metformin attempt.¹
Step 1 Metformin — the standard medication

Metformin has been considered the standard first-choice therapy for decades. Among other things, it inhibits the liver's sugar production and improves insulin sensitivity. In contrast to insulin or sulfonylureas, it generally does not cause hypoglycemia, is mostly weight-neutral and well studied.¹

Metformin (e.g. Glucophage, various generics)
Intake: Generally dosed gradually and together with food — in order to reduce gastrointestinal complaints
Side effects: Nausea, diarrhea, flatulence (improve in many of those affected after a few weeks). The extended-release form is often better tolerated
Contraindication: Strongly limited kidney function — regular kidney monitoring necessary
More: Taking medications before or after meals
Step 2 Combination — often early with a heart or kidney disease
SGLT2 inhibitors (gliflozins) — heart and kidney protection
Examples: empagliflozin (Jardiance), dapagliflozin (Forxiga)
Mode of action: Sugar is increasingly excreted via the urine
Additional benefit: In large studies (EMPA-REG, DAPA-CKD) favorable effects on heart failure and kidney function proven. According to the guideline, use early with relevant heart or kidney diseases.¹
Side effects: Genital fungal infections and urinary tract infections. More rarely: euglycemic ketoacidosis (also possible with normal blood sugar values — clarify medically)
GLP-1 receptor agonists — blood sugar, weight and heart protection
Examples: semaglutide (Ozempic as an injection, Rybelsus as a tablet), dulaglutide (Trulicity), liraglutide (Victoza), tirzepatide (Mounjaro — a dual GLP-1/GIP agonist)
Mode of action: Mimic the gut hormone GLP-1 — can increase the insulin release, slow down the gastric emptying and act on the satiety center
Additional benefit: A cardiovascular benefit proven for several substances in certain patient groups (among others semaglutide, tirzepatide)
Side effects: Nausea, vomiting, constipation at the beginning — gradual dose escalation generally helps
In development: Orforglipron (an oral GLP-1 tablet without a fasting requirement), CagriSema (semaglutide + an amylin analogue)
DPP-4 inhibitors (gliptins)
Examples: sitagliptin (Januvia), linagliptin (Trajenta)
Well tolerated, mostly cause no hypoglycemia. The blood-sugar lowering is on average weaker than with SGLT2 inhibitors or GLP-1 RAs. No additional cardiovascular benefit proven in studies.
Sulfonylureas
Examples: glibenclamide, glimepiride
Lower the blood sugar reliably, but carry a risk of hypoglycemia and can contribute to weight gain. Today they are generally used more rarely than in the past — mostly only in certain constellations.¹
Step 3 Triple combination or insulin

When a double combination is not sufficient, a further step can make sense — e.g. the combination of metformin, an SGLT2 inhibitor and a GLP-1 receptor agonist or the additional administration of a basal insulin. The use of insulin with type 2 is generally not a "failure" of the therapy, but reflects the natural course of the disease.¹

Do not stop medications on your own Diabetes medications should generally not be stopped on one's own or changed in dose — the blood sugar can otherwise derail. Always discuss changes with the diabetes team. More: Stopping medications, Checking interactions.

8. Complications and secondary diseases

Acute complications

Hypoglycemia (low blood sugar) — act immediately Typical warning signs: trembling, sweating, a racing heart, ravenous hunger, concentration problems or confusion. Immediate measure: take in fast carbohydrates. Important: hypoglycemia occurs above all under insulin and sulfonylureas — under metformin, SGLT2 inhibitors or GLP-1 RAs alone it is considerably more rare.
Hyperosmolar derailment — call 112 immediately! (in the US: 911) Very high blood sugar, severe dehydration, increasing clouding of consciousness — a medical emergency.

Chronic secondary diseases

Many of the possible secondary diseases can be delayed or avoided through good metabolic control, regular checks and the treatment of further risk factors:

  • Eyes (diabetic retinopathy) — one of the common causes of severe deteriorations of vision; annual ophthalmological checks important
  • Kidneys (diabetic nephropathy) — regular checking of the kidney values and the albumin in the urine
  • Nerves (diabetic neuropathy) — tingling, numbness, diabetic foot syndrome
  • Cardiovascular — a considerably increased risk for a heart attack and stroke; cardiovascular diseases are among the most common causes of death with type 2
  • Fatty liver (MASLD)
  • Erectile dysfunction
  • Depression — more common in people with diabetes than in the general population

9. Check-up examinations

  • Quarterly: HbA1c, blood pressure, inspection of the feet, if applicable a discussion of the blood-sugar self-measurement
  • Annually: an ophthalmological examination, kidney values (eGFR + albumin in the urine), blood lipids, a structured foot examination, a cardiovascular assessment
  • Regularly too: checking for neuropathy and peripheral arterial occlusive disease (PAD)
  • Dental checks — periodontitis can occur more often in people with diabetes

10. Living with type 2 diabetes

  • Blood-sugar measurement: How often it should be measured depends on the therapy. Under metformin alone, a daily self-measurement is mostly not necessary. Under insulin or sulfonylureas it is usually measured regularly.
  • Alcohol: In combination with insulin or sulfonylureas, alcohol can increase the risk of hypoglycemia — generally not on an empty stomach. More: Medications and alcohol.
  • Travel: Take along medications in a sufficient quantity (usually double), transport insulin cool (do not freeze), a medical certificate for injections and the pen in carry-on luggage. More: Medications when traveling.
  • Vaccinations: For people with diabetes, the STIKO generally recommends the annual flu vaccination as well as — depending on the individual situation — COVID-19 and pneumococcal vaccinations.
  • Driver's license: Type 2 diabetes is generally not a fundamental obstacle. Under insulin or sulfonylurea therapy, a blood-sugar check before starting to drive is often sensible.

How brite helps you with type 2 diabetes

brite brings structure to your diabetes therapy — from metformin to the diabetologist's appointment.

  • Intake reminder — metformin, the weekly GLP-1 injection, blood pressure reducer or statin: brite reminds you reliably. Set up a reminder
  • Interaction check — check diabetes medications in combination with blood pressure reducers, statins or painkillers. Check now
  • Health history — document blood sugar, HbA1c, weight and blood pressure over time and recognize patterns. Track your history
  • Digital medication plan — all medications clearly organized for the diabetologist, GP, pharmacy and emergency room. Go to medication plan
Start now for free
brite App

FAQ: Common questions about type 2 diabetes

Not in the classic sense, but a remission is possible in individual cases: through consistent weight loss, a dietary change and movement, some of those affected can manage without medications for a time. The earlier this is begun, the better the chances often are. With pronounced obesity, remissions are also described after bariatric operations. A relapse risk exists — that is why regular checks remain important.¹
In most cases not immediately — many people with type 2 initially manage with tablets and/or GLP-1 receptor agonists. Insulin is generally only added when other options are no longer sufficient or one's own insulin production declines strongly. The transition to insulin is mostly not a "therapy failure".
Both are GLP-1 receptor agonists. Ozempic contains the active ingredient semaglutide, Mounjaro the active ingredient tirzepatide. They can lower the blood sugar, influence the appetite and lead to weight loss in a portion of those treated. For several substances from this group, a cardiovascular benefit in certain patient groups has been shown in studies.
Prediabetes denotes a precursor of type 2 diabetes: the blood sugar is elevated, but not yet in the diabetes range (e.g. fasting blood sugar 100–125 mg/dl or HbA1c 5.7–6.4%). Without countermeasures, a diabetes develops over the course in many cases. A structured lifestyle change can considerably lower the risk for a transition.¹
Under 5.7% mostly counts as normal, 5.7–6.4% as prediabetes, from 6.5% as diabetes. The individual therapy goal under treatment is often under 7.0% — but depending on age, accompanying diseases and the risk of hypoglycemia it can also be set higher. The determination always happens individually with the doctor.¹
A permanently elevated blood sugar can over years lead to damage to the eyes, kidneys, nerves and vessels. Possible are considerable deteriorations of vision, a worsening of kidney function up to the point of requiring dialysis, problems at the feet and a considerably increased risk for a heart attack or stroke.
With diagnosed type 2 diabetes, Ozempic and Mounjaro are generally covered by the statutory health insurers in Germany. With obesity without diabetes, the situation is mostly different — here the preparations currently count as so-called lifestyle medicines. When in doubt, ask your own health insurer. (Coverage in the US depends on your insurance plan and differs from Germany.)
Gastrointestinal complaints are common under metformin in the first weeks and improve in many of those affected over time. Generally helpful are a gradual dose increase and the intake with food. The extended-release form is often better tolerated. If the complaints persist, the approach should be discussed with the doctor — do not stop on your own.

13. Related topics

Sources

  1. Nationale VersorgungsLeitlinie Typ-2-Diabetes, Version 3 (ÄZQ/AWMF, Dezember 2024). awmf.org
  2. NVL Typ-2-Diabetes — Kapitel Medikamentöse Therapie. leitlinien.de
  3. Robert Koch-Institut: Diabetes mellitus — Prävalenz bei Erwachsenen (Panelauswertung 2024). gbe.rki.de
  4. Robert Koch-Institut: Nationale Diabetes-Surveillance — Ergebnisse 2015–2024. diabsurv.rki.de
  5. Deutsche Diabetes Gesellschaft (DDG): Gesundheitsbericht Diabetes und Factsheet. ddg.info
  6. Publikationen zu kardiovaskulären Effekten von Semaglutid und Tirzepatid (Nature Medicine, 2025). nature.com
  7. diabinfo.de — Medikamente bei Typ-2-Diabetes. diabinfo.de
  8. gesundheitsinformation.de (IQWiG): Typ-2-Diabetes. gesundheitsinformation.de
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or therapy. Dosages, the choice of medication and therapy goals (e.g. the individual HbA1c target value) are always determined individually by the treating diabetes team. With unconsciousness or extremely high blood sugar, immediately call the emergency number 112 (in the US: 911). Diabetes medications should generally not be stopped on one's own. Last updated: April 2026.